1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Prefilled Syringes Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Design
6.1 Single-chamber Prefilled Syringes
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Dual-chamber Prefilled Syringes
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Customized Prefilled Syringes
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Material
7.1 Glass Prefilled Syringes
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Plastic Prefilled Syringes
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Closing System
8.1 Staked Needle System
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Luer Cone System
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Luer Lock Form System
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Application
9.1 Diabetes
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Anaphylaxis
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Rheumatoid Arthritis
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Oncology
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Abbott Laboratories
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 B. Braun Melsungen AG
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Baxter International Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bayer AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Becton Dickinson and Company
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Cardinal Health Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Catalent Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Fresenius SE & Co. KGaA
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Gerresheimer AG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 Nipro Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.10.3 Financials
16.3.10.4 SWOT Analysis
16.3.11 Schott AG
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 SWOT Analysis
16.3.12 Terumo Corporation
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio
16.3.12.3 Financials
16.3.12.4 SWOT Analysis
16.3.13 West Pharmaceutical Services Inc.
16.3.13.1 Company Overview
16.3.13.2 Product Portfolio
16.3.13.3 Financials
16.3.13.4 SWOT Analysis
世界のプレフィルドシリンジ市場予測2023年-2028年 |
| 【英語タイトル】Prefilled Syringes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 | |
 | ・商品コード：IMARC23FE0153 ・発行会社（調査会社）：IMARC ・発行日：2023年2月1日 ・ページ数：147 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール ・調査対象地域：グローバル ・産業分野：医療機器 |
| Single User | USD2,999 ⇒換算￥455,848 | 見積依頼/購入/質問フォーム |
| Five User | USD3,999 ⇒換算￥607,848 | 見積依頼/購入/質問フォーム |
| Enterprisewide | USD4,999 ⇒換算￥759,848 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| IMARC社の調査レポートによると、世界のプレフィルドシリンジ市場規模は2022年70億ドルに達しました。今後、2028年には118億ドルまで拡大し、2023年から2028年の間に年平均8.8％で成長すると予測されます。本レポートでは、プレフィルドシリンジの世界市場について調査・分析し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、デザイン別（シングルチャンバープレフィルドシリンジ、デュアルチャンバープレフィルドシリンジ、カスタマイズプレフィルドシリンジ）分析、材料別（ガラスプレフィルドシリンジ、プラスチック製プレフィルドシリンジ）分析、クロージングシステム別（ステーキドニードルシステム、ルアーコーンシステム、ルアーロックフォームシステム）分析、用途別（糖尿病、アナフィラキシー、関節リウマチ、腫瘍、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下の構成でお届けします。なお、本書には、Bruker Corporation, Canon Medical Systems Usa Inc., General Electric Company, Hitachi Ltd., Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Positron Corporation, Shimadzu Corporation, Siemens Healthcare GmbH (Siemens AG), Sofie Biosciences Inc., United Imaging Healthcare Co. Ltd. and Yangzhou Kindsway Biotech Co. Ltd.などの企業情報が含まれています。 ・序論 ・範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界のプレフィルドシリンジ市場規模：デザイン別 - シングルチャンバープレフィルドシリンジの市場規模 - デュアルチャンバープレフィルドシリンジの市場規模 - カスタマイズプレフィルドシリンジの市場規模 ・世界のプレフィルドシリンジ市場規模：材料別 - ガラスプレフィルドシリンジの市場規模 - プラスチック製プレフィルドシリンジの市場規模 ・世界のプレフィルドシリンジ市場規模：クロージングシステム別 - ステーキドニードルシステムの市場規模 - ルアーコーンシステムの市場規模 - ルアーロックフォームシステムの市場規模 ・世界のプレフィルドシリンジ市場規模：用途別 - 糖尿病用プレフィルドシリンジの市場規模 - アナフィラキシー用プレフィルドシリンジの市場規模 - 関節リウマチ用プレフィルドシリンジの市場規模 - 腫瘍用プレフィルドシリンジの市場規模 - その他用途の市場規模 ・世界のプレフィルドシリンジ市場規模：地域別 - 北米のプレフィルドシリンジ市場規模 - アジア太平洋のプレフィルドシリンジ市場規模 - ヨーロッパのプレフィルドシリンジ市場規模 - 中南米のプレフィルドシリンジ市場規模 - 中東・アフリカのプレフィルドシリンジ市場規模 ・SWOT分析 ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global prefilled syringes market size reached US$ 7.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.8 Billion by 2028, exhibiting a growth rate (CAGR) of 8.8% during 2023-2028.
A prefilled syringe is a single-dose packet of injectable vaccines that is disposable in nature. The usage of prefilled syringes significantly lowers the chances of drug contamination as it avoids the potential admixture-related contamination risks when syringes are inserted into a drug vial to draw out a dose. Combining this with a pre-sterilized syringe further increases safety, enables the easy and quick delivery of drugs in the case of emergencies, and eliminates the additional on-site vial cleaning and de-pyrogenation processes. Consequently, they are a preferred option to administer the drugs via the parenteral route for delivering a wide range of injectables, such as biosimilar and biologics.
Prefilled Syringes Market Trends:
The global market is primarily driven by the increasing incidences of chronic diseases, including diabetes and autoimmune diseases. This is further supported by the growing demand for treating chronic medical conditions using biological drugs in pre-fillable syringes. In addition to this, the widespread adoption of the prefilled syringe products by healthcare professionals and the escalating number of new product launches by key players are also fostering the market. Moreover, with significant technological advancements, the implementations of self-injecting parenteral devices are also increasing, which, in turn, is contributing to the market growth. The market is also driven by the rising geriatric population on the global level and growing investments in improving the overall healthcare infrastructure. Other factors, such as supportive government regulations regarding needlestick legislation, the rising consciousness regarding the advantages of prefilled syringes, the widespread preference for home-based healthcare, and the increasing popularity of biologics and biosimilars across the pharmaceutical settings, are further creating lucrative growth opportunities in the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global prefilled syringes market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on design, material, closing system, application and end user.
Breakup by Design:
Single-chamber Prefilled Syringes
Dual-chamber Prefilled Syringes
Customized Prefilled Syringes
Breakup by Material:
Glass Prefilled Syringes
Plastic Prefilled Syringes
Breakup by Closing System:
Staked Needle System
Luer Cone System
Luer Lock Form System
Breakup by Application:
Diabetes
Anaphylaxis
Rheumatoid Arthritis
Oncology
Others
Breakup by End User:
Hospitals
Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun Melsungen AG, Baxter International Inc., Bayer AG, Becton Dickinson and Company, Cardinal Health Inc., Catalent Inc., Fresenius SE & Co. KGaA, Gerresheimer AG, Nipro Corporation, Schott AG, Terumo Corporation and West Pharmaceutical Services Inc.
Key Questions Answered in This Report:
How has the global prefilled syringes market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global prefilled syringes market?
What are the key regional markets?
What is the breakup of the market based on the design?
What is the breakup of the market based on the material?
What is the breakup of the market based on the closing system?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global prefilled syringes market and who are the key players?
What is the degree of competition in the industry?
❖ レポートの目次 ❖
| ★調査レポート[世界のプレフィルドシリンジ市場予測2023年-2028年] (コード：IMARC23FE0153)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のプレフィルドシリンジ市場予測2023年-2028年]についてメールでお問い合わせ |
